Inactive Instrument

Forest Laboratories, Inc. Share Price

Stocks

End-of-day quote NYSE Other stock markets
- ^USD	-

06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/05/14	Actavis : M&A frenzy in healthcare sector	RE

06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/05/14	Actavis : M&A frenzy in healthcare sector	RE
14/04/14	Actavis : Investors support deals spree, happy to see U.S. companies buy growth	RE
10/04/14	Icahn backs down from demand that eBay spin off PayPal	RE
20/02/14	Suntory Beverage & Food Ltd : Goldman Sachs misses out on WhatsApp, 2014's top deals so far	RE
19/02/14	Icahn says Actavis-Forest deal validates shareholder activism	RE
18/02/14	Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
18/02/14	Actavis PLC : Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
18/02/14	Actavis PLC : Actavis in talks to buy Forest Labs for as much as $25 billion - WSJ	RE
08/01/14	S&P 500 ends flat in wake of Fed minutes	RE
08/01/14	Forest Laboratories, Inc. : Forest Labs to buy Aptalis from TPG for $2.9 billion	RE
08/01/14	Evercore Partners Inc. : Forest Labs nears $3 billion deal for Aptalis - source	RE
23/10/13	Elan Corporation, plc : Exclusive - TPG-backed Aptalis Pharma hires banks for an IPO: sources	RE

30/06/14	Forest Laboratories : Actavis and Forest Receive U.S. FTC Clearance for Actavis’ Proposed Acquisition of Forest	BU
30/06/14	Forest Laboratories : Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results	BU
23/06/14	Forest Laboratories : Announces Positive Topline Results from Three Phase III Trials for Vilazodone in the Treatment of Generalized Anxiety Disorder (GAD)	BU
23/06/14	Forest Laboratories : Actavis and Forest Laboratories Announce Appointment of C. David Nicholson, PhD to lead Actavis Global Brands Research and Development	BU
20/06/14	Forest Laboratories : to Present Cariprazine Data at the International College of Neuropsychopharmacology World Congress	BU

17/11/16	Devisen: Euro fällt zum USD weiter - Hinweise auf US-Zinserhöhung belasten
28/04/14	Bank of America : Wall Street ouvre en hausse, les pharmaceutiques en vue
28/04/14	Wall Street ouvre en hausse, les pharmaceutiques en vue
28/04/14	Actavis : Forest Laboratories achète Furiex pour 1,46 milliard de dollars
28/04/14	Forest Laboratories : Pharmacie-Forest achète Furiex pour $1,46 milliard

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+1.40%	+1.59%	+48.72%	+160.78%	1,057B
JOHNSON & JOHNSON	+1.53%	+3.87%	+55.01%	+53.63%	624B
ABBVIE INC.	+1.08%	+1.83%	+35.80%	+81.00%	454B
ROCHE HOLDING AG	+1.60%	+6.25%	+33.95%	+29.84%	341B
NOVARTIS AG	-0.60%	+1.52%	+35.68%	+39.76%	297B
ASTRAZENECA PLC	-0.14%	+0.60%	+16.17%	+17.53%	262B
NOVO NORDISK A/S	+0.09%	-2.82%	-28.29%	-41.71%	215B
AMGEN INC.	+1.47%	+2.64%	+21.84%	+59.69%	201B
GILEAD SCIENCES, INC.	-0.39%	-3.14%	+14.90%	+67.49%	162B
Average	+0.72%	+0.77%	+25.98%	+52.00%	401.55B
Weighted average by Cap.	+0.98%	+1.57%	+35.76%	+77.70%